It is widely recognized that the acute radiation after exposure to penetrating ionizing radiations in the lethal dose range is the resultant, primarily, of injury to the gastrointestinal epithelium, on the one hand, and the bone marrow and lymphoid tissues, on the other (1-3). At supralethal whole-body X-radiation dose levels in the mouse, of the order of 1100 r, it is known that the acute radiation syndrome (4, 5), characterized by early (4to 6-day) radiation mortality, is the predominant mode of death. In contrast, at radiation doses of 800 r (an LD0oo dose), the great majority of untreated mice die during the second and third weeks postirradiation as a consequence of a involving defects in the hematopoietic system, and infection (5). The latter is known to be amenable to therapy by parenterally administered bone marrow cell suspensions, spleen homogenates, and spleen implants, which elicit accelerated regeneration of the hematopoietic tissues (6-9), and retard or prevent infection (10, 11). Our knowledge of the pathogenesis of the intestinal phase of acute radiation death (5, 12) and other related data in the literature (9, 13-16), suggest that radiation injury to the intestinal mucosa and subsequent regeneration processes are largely independent of the corresponding events in the hematopoietic tissues. Thus, accelerated regeneration of deoxyribonucleic acid biosynthesis in bone marrow and spleen of X-irradiated animals, induced by injection of bone marrow cell suspensions or spleen homogenates, is not accompanied by accelerated regeneration of intestinal mucosa (9, 16). In view of these considerations it was of interest to investigate the effect of isologous bone marrow injection on mice exposed to whole-